Hunter R. Murdock
General Counsel, Axsome Therapeutics.
Companies
- Axsome TherapeuticsGeneral counsel Jun 15, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Axsome Therapeutics AXSM0 shares2Jun 23, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 23, 2025Sold 6,014 shares at $100.12 of Axsome Therapeutics2
- Jun 23, 2025Exercised options 6,014 shares at $29.91 of Axsome Therapeutics2
- Jun 20, 2025Sold 7,500 shares at $102.47 of Axsome Therapeutics2
- Jun 20, 2025Exercised options 7,500 shares at $29.91 of Axsome Therapeutics2
- Jun 18, 2025Sold 7,500 shares at $100.90 of Axsome Therapeutics3
- Jun 18, 2025Exercised options 7,500 shares at $29.91 of Axsome Therapeutics3
- Jun 17, 2025Sold 7,500 shares at $100.26 of Axsome Therapeutics3
- Jun 17, 2025Exercised options 7,500 shares at $29.91 of Axsome Therapeutics3
- Jun 16, 2025Sold 7,500 shares at $102.42 of Axsome Therapeutics3
- Jun 16, 2025Exercised options 7,500 shares at $29.91 of Axsome Therapeutics3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAxsome Therapeutics, General counsel
- 2
- 3SEC EDGARForm 4 filed Jun 18, 2025